Fingerprint
Dive into the research topics of 'Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial
Neurofibromatosis Clinical Trials Consortium
Research output: Contribution to journal › Article › peer-review
12
Scopus
citations